Plain-English translation of NCT06975579 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing a new computer algorithm called COSIE that improves how ultrasound detects fatty liver disease—a common side effect of cancer treatment. The algorithm helps select the best parts of the liver to measure, making ultrasound results more reliable and accurate. This study will compare the algorithm's results against MRI imaging to see if it works as well.
Fatty liver disease is becoming increasingly common, especially in cancer patients receiving treatment. While ultrasound is a cheap and widely available way to detect it, the measurements can be unreliable. This trial exists to see if the new algorithm can make ultrasound measurements more trustworthy, potentially allowing doctors to catch fatty liver disease earlier in more patients.
You likely qualify if…
You likely don't qualify if…
If you participate, you will have ultrasound scans of your liver taken while you are also undergoing or have recently had an MRI scan as part of your care. The researchers will use the new COSIE algorithm on your ultrasound images and compare the results to your MRI to see how accurate the algorithm is. The study involves 15 participants total and takes place at the Royal Marsden Hospital or Institute of Cancer Research.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United Kingdom